FDA Import Refusal 799-3263837-6/1/1 — UCB Pharma S.A.

UCB Pharma S.A. — FEI 3003909356

The FDA refused shipment 799-3263837-6/1/1 from UCB Pharma S.A. (Belgium) on May 2, 2014. The refused product falls under Drugs and Biologics — LEVETIRACETAM (ANTI-CONVULSANT). Cited charge: 75 This firm has 5 or more other import refusals on record.